Target Name: KCNAB3
NCBI ID: G9196
Review Report on KCNAB3 Target / Biomarker Content of Review Report on KCNAB3 Target / Biomarker
KCNAB3
Other Name(s): KCAB3_HUMAN | potassium channel, voltage gated subfamily A regulatory beta subunit 3 | K+ channel beta-3 subunit | potassium channel, voltage-dependent, beta-3 subunit | K(+) channel subunit beta-3 | KV-BETA-3 | AKR6A9 | Potassium voltage-gated channel subfamily A regulatory beta subunit 3 | potassium voltage-gated channel, shaker-related subfamily, beta member 3 | potassium voltage-gated channel subfamily A regulatory beta subunit 3 | KCNA3B | Potassium voltage-gated channel, shaker-related subfamily, beta member 3 | Potassium channel, voltage-dependent, beta-3 subunit | MGC116886 | KCNA3.1B | Kv-beta-3 | Voltage-gated potassium channel subunit beta-3

KCNAB3: A Potential Drug Target and Biomarker

KCNAB3 (KCAB3_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. The protein is a member of the馃槈 family, which is known for its role in intracellular signaling pathways. KCNAB3 has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion.

One of the key functions of KCNAB3 is its role in cell-cell adhesion. This protein is involved in the formation of tight junctions, which are a type of cell-cell adhesion that helps to maintain tissue structure and prevent the passage of foreign particles into the body. tight junctions are critical for the proper functioning of various tissues, including the skin, heart, and lungs.

KCNAB3 is also involved in the regulation of cell migration. This protein helps to maintain the shape and structure of cells, which is essential for their movement through the body. During the development of tissues, cells must move and specialize in order to create the diverse array of cell types that make up the body. KCNAB3 plays a critical role in this process by helping to ensure that cells maintain their proper shape and structure.

Another function of KCNAB3 is its role in cell invasion. This protein helps to promote the migration of cells through the body's tissues. When a cell wants to invade a new tissue, it needs to be able to break through the surrounding cells and migrate towards its destination. KCNAB3 plays a critical role in this process by helping to provide the structural support that cells need to migrate through the body.

In addition to its role in cell-cell adhesion, migration, and invasion, KCNAB3 is also involved in the regulation of cellular signaling pathways. This protein helps to transmit signals between cells, and is involved in the regulation of various signaling pathways that are important for cellular growth and development.

Despite the many important functions of KCNAB3, it is still a relatively little-known protein. There is currently limited research on the specific mechanisms that this protein is involved in, and more research is needed to fully understand its role in the regulation of cellular processes.

In conclusion, KCNAB3 is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. This protein plays a critical role in the regulation of cell-cell adhesion, migration, and invasion, and is involved in the regulation of cellular signaling pathways. Further research is needed to fully understand its role in the body and its potential as a drug target.

Protein Name: Potassium Voltage-gated Channel Subfamily A Regulatory Beta Subunit 3

Functions: Accessory potassium channel protein which modulates the activity of the pore-forming alpha subunit. Alters the functional properties of Kv1.5

The "KCNAB3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNAB3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KCNB1 | KCNB2 | KCNC1 | KCNC2 | KCNC3 | KCNC4 | KCND1 | KCND2 | KCND3 | KCNE1 | KCNE2 | KCNE3 | KCNE4 | KCNE5 | KCNF1 | KCNG1 | KCNG2 | KCNG3 | KCNG4 | KCNH1 | KCNH2 | KCNH3 | KCNH4 | KCNH5 | KCNH6 | KCNH7 | KCNH7-AS1 | KCNH8 | KCNIP1 | KCNIP1-OT1 | KCNIP2 | KCNIP3 | KCNIP4 | KCNIP4-IT1 | KCNJ1 | KCNJ10 | KCNJ11 | KCNJ12 | KCNJ13 | KCNJ14 | KCNJ15 | KCNJ16 | KCNJ18 | KCNJ2 | KCNJ2-AS1 | KCNJ3 | KCNJ4 | KCNJ5 | KCNJ5-AS1 | KCNJ6 | KCNJ8 | KCNJ9 | KCNK1 | KCNK10 | KCNK12 | KCNK13 | KCNK15 | KCNK15-AS1 | KCNK16 | KCNK17 | KCNK18 | KCNK2 | KCNK3 | KCNK4 | KCNK5 | KCNK6 | KCNK7 | KCNK9 | KCNMA1 | KCNMB1 | KCNMB2 | KCNMB2-AS1 | KCNMB3 | KCNMB4 | KCNN1 | KCNN2 | KCNN3 | KCNN4 | KCNQ Channels (K(v) 7) | KCNQ1 | KCNQ1DN | KCNQ1OT1 | KCNQ2 | KCNQ3 | KCNQ4 | KCNQ5 | KCNQ5-AS1 | KCNQ5-IT1 | KCNRG | KCNS1 | KCNS2 | KCNS3 | KCNT1 | KCNT2 | KCNU1 | KCNV1 | KCNV2 | KCP | KCTD1 | KCTD10